Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 825 of 3173 entries
View as:

Palatability (Taste) of Oral Formulations of Bosutinib

Phase: N/A Priority: Normal
NCT ID: NCT03747679 Org: User:
Start: 11/22/18 End: 01/14/19 Due: 01/14/20

Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate

Phase: N/A Priority: Normal
NCT ID: NCT00939562 Org: User:
Start: 11/30/08 End: 12/31/08 Due: 12/31/09

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)

Phase: N/A Priority: Normal
NCT ID: NCT05573555 Org: User:
Start: 03/01/23 End: 12/30/26 Due: 12/30/27

Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary

Phase: N/A Priority: Normal
NCT ID: NCT00174278 Org: User:
Start: 02/28/97 End: 10/31/06 Due: 10/31/07

Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00113529 Org: User:
Start: 10/31/04 End: 10/31/08 Due: 10/31/09

Phase 1 Clinical Trial of Varenicline in Chinese Healthy Smoking Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00452894 Org: User:
Start: 03/31/07 End: 03/31/07 Due: 03/31/08

Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003343 Org: User:
Start: 03/31/98 End: - Due: -

Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect

Phase: N/A Priority: Normal
NCT ID: NCT00807118 Org: User:
Start: 10/31/08 End: 12/31/08 Due: 12/31/09

A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00435409 Org: User:
Start: 02/28/07 End: 06/30/11 Due: 06/30/12

A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883.

Phase: N/A Priority: Normal
NCT ID: NCT05884554 Org: User:
Start: 06/15/23 End: 06/27/24 Due: 06/27/25

A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT03760029 Org: User:
Start: 07/24/19 End: 03/21/23 Due: 03/21/24

Relative Bioavailability Of A Crizotinib Oral Liquid Formulation To Crizotinib Formulated Capsule

Phase: N/A Priority: Normal
NCT ID: NCT01297595 Org: User:
Start: 03/31/11 End: 04/30/11 Due: 04/30/12

A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years

Phase: N/A Priority: Normal
NCT ID: NCT02561195 Org: User:
Start: 07/16/15 End: 02/13/20 Due: 02/13/21

An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)

Phase: N/A Priority: Normal
NCT ID: NCT00002090 Org: User:
Start: - End: - Due: -

Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04099563 Org: User:
Start: 10/14/19 End: 12/09/19 Due: 12/09/20

Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT01945021 Org: User:
Start: 09/30/13 End: 01/22/20 Due: 01/22/21

A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant

Phase: N/A Priority: Normal
NCT ID: NCT06275841 Org: User:
Start: 02/23/24 End: 05/24/24 Due: 05/24/25

A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00417885 Org: User:
Start: 06/30/07 End: 07/31/09 Due: 07/31/10

A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05673889 Org: User:
Start: 01/27/23 End: 04/19/23 Due: 04/19/24

A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT04047121 Org: User:
Start: 05/20/19 End: 10/21/19 Due: 10/21/20

Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01089582 Org: User:
Start: 11/30/07 End: 07/31/09 Due: 07/31/10

A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00424294 Org: User:
Start: 06/30/06 End: 02/29/08 Due: 02/28/09

Maintenance of Efficacy.

Phase: N/A Priority: Normal
NCT ID: NCT00796601 Org: User:
Start: 05/01/09 End: 11/01/10 Due: 11/01/11

A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02193815 Org: User:
Start: 09/30/14 End: 02/28/15 Due: 02/28/16

Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events

Phase: N/A Priority: Normal
NCT ID: NCT01968954 Org: User:
Start: 10/31/13 End: 04/30/16 Due: 04/30/17